Fortress Biotech (FBIO) EBT Margin (2015 - 2026)
Fortress Biotech (FBIO) posted quarterly EBT Margin of 44.2% for Q4 2025, up 12715.0% year-over-year from N/an in Q4 2024, and down 188.03% quarter-over-quarter from 50.21% in Q3 2025.
Powered by 
Analysis
Fortress Biotech (FBIO) EBT Margin (2015 - 2026) Analysis & Trends
Fortress Biotech's EBT Margin history runs 11 years deep, the most recent figure standing at 44.2% for Q4 2025.
- In Q4 2025, EBT Margin rose 12715.0% year-over-year to 44.2%; the TTM figure through Dec 2025 stood at 103.12% (up 10500.0% YoY), while the FY2025 annual figure was 54.76%, up 15424.0% from the prior year.
- EBT Margin for Q4 2025 stood at 44.2%, down from 50.21% in the prior quarter.
- The five-year high for EBT Margin was 99.2% in Q4 2022, with the low at 30500.0% in Q2 2023.
- The 5-year median for EBT Margin is 268.41% (2021), against an average of 4768.16%.
- The sharpest annual moves came in 2023 and 2024: EBT Margin slumped 3020425 bps in 2023, then jumped 3030414 bps in 2024.
- Fortress Biotech's EBT Margin stood at 101.53% in 2021, then jumped by 198 bps to 99.2% in 2022, then slumped by 289 bps to 187.49% in 2023, then climbed by 9 bps to 171.35% in 2024, then soared by 74 bps to 44.2% in 2025.
- Business Quant data shows FBIO's EBT Margin at 44.2% in Q4 2025, 50.21% in Q3 2025, and 260.25% in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | -528.97% |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 18.33% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 13.77% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 12.09% |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -2.67% |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | 4.93% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.93% |
| Dec 31, 2025 | -38.64% |
| Sep 30, 2025 | 50.21% |
| Jun 30, 2025 | -71.00% |
| Mar 31, 2025 | -187.47% |
| Dec 31, 2024 | -171.82% |
| Sep 30, 2024 | -182.00% |
| Jun 30, 2024 | -195.86% |
| Mar 31, 2024 | -294.21% |
| Dec 31, 2023 | -143.41% |
| Sep 30, 2023 | -30.45% |
| Jun 30, 2023 | -321.03% |
| Mar 31, 2023 | -499.86% |
| Dec 31, 2022 | -347.45% |
| Sep 30, 2022 | -321.03% |
| Jun 30, 2022 | -295.75% |
| Mar 31, 2022 | -206.80% |
| Dec 31, 2021 | -370.83% |
| Sep 30, 2021 | -257.22% |
| Jun 30, 2021 | -254.84% |